Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Chemico-Biological Interactions

• Publication date

  2012-05-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cbi.2012.03.010PMID 22521999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of ferritin alterations in human breast cancer cells

  2011cited by this paper
• Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.

  2011cited by this paper
• The Potent and Novel Thiosemicarbazone Chelators Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-Benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone Affect Crucial Thiol Systems Required for Ribonucleotide Reductase Activity

  2011cited by this paper
• Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.

  2011cited by this paper
• Cellular Iron Depletion Stimulates the JNK and p38 MAPK Signaling Transduction Pathways, Dissociation of ASK1-Thioredoxin, and Activation of ASK1*

  2011cited by this paper
• Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic Cancer

  2011cited by this paper
• Halogenated 2'-benzoylpyridine thiosemicarbazone (XBpT) chelators with potent and selective anti-neoplastic activity: relationship to intracellular redox activity.

  2011cited by this paper
• Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis.

  2011influential reference
• Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.

  2011cited by this paper
• Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.

  2010cited by this paper
• Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells.

  2010cited by this paper
• Ferroportin and iron regulation in breast cancer progression and prognosis.

  2010cited by this paper
• Chelation of lysosomal iron protects against ionizing radiation.

  2010cited by this paper
• Effects of Iron Deprivation on Multidrug Resistance of Leukemic K562 Cells

  2010cited by this paper
• Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia

  2010cited by this paper
• The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: an EPR study.

  2010cited by this paper
• Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells

  2010cited by this paper
• The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity.

  2009cited by this paper
• Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.

  2009cited by this paper
• Iron stores in chronic granulocytic leukaemia at presentation.

  2009cited by this paper
• Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis

  2009cited by this paper
• 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.

  2009cited by this paper
• Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.

  2009cited by this paper
• Synthetic and natural iron chelators: therapeutic potential and clinical use.

  2009cited by this paper
• Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells

  2009cited by this paper
• Investigation of the stability of aromatic hydrazones in plasma and related biological material.

  2008cited by this paper
• The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets.

  2008cited by this paper
• Neutral red uptake assay for the estimation of cell viability/cytotoxicity

  2008cited by this paper
• Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone

  2008cited by this paper
• Levels of Zinc, Selenium, Calcium, and Iron in Benign Breast Tissue and Risk of Subsequent Breast Cancer

  2007cited by this paper
• Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands

  2007cited by this paper
• Trace element concentration distributions in breast, lung and colon tissues

  2007cited by this paper
• Dietary flavonoid apigenin is a potential inducer of intracellular oxidative stress: the role in the interruptive apoptotic signal.

  2007cited by this paper
• Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).

  2007cited by this paper
• Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion.

  2007cited by this paper
• Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.

  2007cited by this paper
• Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

  2006cited by this paper
• Intralysosomal iron chelation protects against oxidative stress‐induced cellular damage

  2006cited by this paper
• Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.

  2006cited by this paper
• Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study.

  2005cited by this paper
• Metals, toxicity and oxidative stress.

  2005cited by this paper
• Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits

  2005cited by this paper
• SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.

  2005cited by this paper
• The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer

  2005cited by this paper
• Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation.

  2005cited by this paper
• Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment.

  2004cited by this paper
• A study of potential toxic effects after repeated 10-week administration of a new iron chelator--salicylaldehyde isonicotinoyl hydrazone (SIH) to rabbits.

  2003influential reference
• Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties.

  2003cited by this paper
• Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs.

  2003cited by this paper
• Estrogen regulation of transferrin gene expression in MCF-7 human breast cancer cells.

  2002cited by this paper
• Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis*

  2002cited by this paper
• Design

  2001cited by this paper
• The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression.

  2001cited by this paper
• Differing sensitivity of tumor cells to apoptosis induced by iron deprivation in vitro

  2001cited by this paper
• The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes.

  2000cited by this paper
• Disorders of iron metabolism.

  1999cited by this paper
• Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redox cycling of flavonoids.

  1999cited by this paper
• Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

  1998cited by this paper
• The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.

  1997cited by this paper
• The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.

  1995cited by this paper
• Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators.

  1993cited by this paper
• Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.

  1993cited by this paper
• Kinetic and thermodynamic study of complex formation between iron(II) and pyridoxal isonicotinoylhydrazone and other synthetic chelating agents

  1992cited by this paper
• Iron chelators of the pyridoxal isonicotinoyl hydrazone class Part II. Formation constants with iron(III) and iron(II)

  1990cited by this paper
• Pyridoxal isonicotinoyl hydrazone. Effective iron chelation after oral administration.

  1990cited by this paper
• Pyridoxal Isonicotinoyl Hydrazone

  1990cited by this paper
• Effects of a single course of deferoxamine in neuroblastoma patients.

  1990cited by this paper
• Antileukemic effects of deferoxamine on human myeloid leukemia cell lines.

  1989cited by this paper
• Secretion of transferrin by human breast cancer cells.

  1989cited by this paper
• Synthesis of new acylhydrazones as iron-chelating compounds

  1988cited by this paper
• Deferoxamine inhibition of human neuroblastoma viability and proliferation.

  1988cited by this paper
• Cytotoxic chelators and chelates 1. Inhibition of DNA synthesis in cultured rodent and human cells by aroylhydrazones and by a copper(II) complex of salicylaldehyde benzoyl hydrazone

  1982cited by this paper
• Serum iron level in acute lymphoblastic leukaemia.

  1978cited by this paper
• Metals

  1942cited by this paper

• Ferroptosis and iron homeostasis in chronic obstructive pulmonary disease: Therapeutic opportunities of iron chelators.

  2025cites this paper
• A review of hydrazide-hydrazone metal complexes’ antitumor potential

  2024cites this paper
• Evaluation of novel pyridoxal isonicotinoyl hydrazone (PIH) derivatives as potential anti‐tuberculosis agents: An in silico investigation

  2024cites this paper
• A review on therapeutic use of iron in cancer treatment

  2024cites this paper
• Synthesis of new heterocyclic N'-(2-hydroxy-3-methoxybenzylidene)-4-oxopiperidine-1-carbohydrazide and its mononuclear metal (II) complexes: spectroscopic characterization, fluorescence, DFT, thermo-kinetic, and antimicrobial studies

  2023cites this paper
• A new hydrazone compound with ester groups: synthesis, spectroscopic studies, crystal structure, and electrochemical supercapacitor applications

  2022cites this paper
• Regulators of epigenetic change in ferroptosis-associated cancer (Review)

  2022cites this paper
• Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression.

  2021cites this paper
• Promising Ag(I) complexes with N-acylhydrazones from aromatic aldehydes and isoniazid against multidrug resistance in tuberculosis

  2021cites this paper
• Synthesis, crystal structure, evaluation of urease inhibition potential and the docking studies of cobalt(III) complex based on barbituric acid Schiff base ligand

  2020cites this paper
• Patterns of cell death induced by metformin in human MCF-7 breast cancer cells.

  2020cites this paper
• Siderophore-Assisted Dissolution of Iron(III) Hydroxide Oxides from Iron-Rich Fossil Matrices.

  2020cites this paper
• Iron and leukemia: new insights for future treatments

  2019cites this paper
• Synthesis and structural characterization of dinuclear Zinc(II) and Europium(III) complexes based on a bis-hydrazone ligand

  2019cites this paper
• Cancer cell growth inhibition by aroylhydrazone derivatives

  2019cites this paper
• The importance of specific solvent–solute interactions for studying UV–vis spectra of light-responsive molecular switches

  2018cites this paper
• Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities.

  2018cites this paper
• The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.

  2018cites this paper
• Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production.

  2018cites this paper
• Synthesis, Spectral and Antibacterial Studies of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Acetone Acetyl hydrazone

  2018cites this paper
• Mixed ligand aroylhydrazone and N-donor heterocyclic Lewis base Cu(II) complexes as potential antiproliferative agents.

  2017cites this paper
• Design and synthesis of conjugated azo-hydrazone analogues using nano BF3·SiO2 targeting ROS homeostasis in oncogenic and vascular progression.

  2017cites this paper
• DNA and BSA binding and cytotoxic properties of copper(II) and iron(III) complexes with arylhydrazone of ethyl 2-cyanoacetate or formazan ligands

  2017cites this paper
• Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications.

  2016cites this paper
• Synthesis and structural characterization of zinc(II) and cobalt(II) complexes based on multidentate hydrazone ligands

  2016cites this paper
• Synthesis, Characterization and Antifungal Activity of Some Metal Complexes Derived From Quinoxaloylhydrazone

  2015cites this paper
• Crystal structure of (E)-N′-(5-bromo-2-hydroxybenzylidene)nicotinohydrazide monohydrate

  2015cites this paper
• Inhibitory effect of iron withdrawal by chelation on the growth of human and murine mammary carcinoma and fibrosarcoma cells.

  2015cites this paper
• Synthesis and biological activity evaluation of hydrazone derivatives based on a Tröger's base skeleton.

  2015cites this paper
• In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites

  2015cites this paper
• An enolato-bridged dinuclear Cu(II) complex with a coumarin-assisted precursor: a spectral, magnetic and biological study

  2015cites this paper
• Synthesis, characterization and antimicrobial activity of copper(II) complexes with hydrazone derived from 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde

  2015cites this paper
• Metal complexes of hydrazones and their biological, analytical and catalytic applications: A review

  2014cites this paper
• Comprehensive ESI-MS and MS/MS analysis of aromatic hydrazones derived from nicotinic acid hydrazide

  2014cites this paper
• Dinuclear organotin(IV) complexes with bis-acyl-hydrazones containing flexible linker: Synthesis, spectroscopic investigation and crystal structure of dimethyl- and diphenyltin(IV) complexes with succinic dihydrazones

  2014cites this paper
• Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities

  2014influential citation
• Iron homeostasis in breast cancer.

  2014cites this paper
• Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.

  2014cites this paper
• Structure-Activity Relationships of Novel Salicylaldehyde Isonicotinoyl Hydrazone (SIH) Analogs: Iron Chelation, Anti-Oxidant and Cytotoxic Properties

  2014influential citation
• Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs

  2014cites this paper
• NOVEL PYRAZINAMIDE DERIVATIVES : MICROWAVE ASSISTED SYNTHESIS AND BIOLOGICAL EVALUATION

  2014cites this paper
• Binuclear organotin(IV) complexes with adipic dihydrazones: Synthesis, spectral characterization, crystal structures and antibacterial activity

  2013cites this paper
• Synthesis, characterization and antioxidant activity of new dibasic tridentate ligands: X-ray crystal structures of DMSO adducts of 1,3-dimethyl-5-acetyl-barbituric acid o-hydroxybenzoyl hydrazone copper(II) complex

  2013cites this paper
• Cytotoxicity and Apoptogenic Activity of A Novel Synthetic Iron Chelator 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-One (CM1) In Human Leukemic Cells

  2013cites this paper
• Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells

  2013cites this paper
• Cellular iron metabolism in prognosis and therapy of breast cancer.

  2013cites this paper